Patent · US Active

Naphthyridinone derivatives and their use in the treatment of arrhythmia

US11530213B2 · kind B2 · utility

0Cited by

9References

16Claims

0Family size

Assignee

Novartis AG · CH

Inventors

Guillaume Barbe · Milton, US
Gregory Raymond Bebernitz · Stow, US
Sicong Geng · Shanghai, CN
Hatice Belgin GULGEZE EFTHYMIOU · Lynn, US
Lv Liao · Shanghai, CN
Fupeng Ma · Cambridge, US
Ruowei MO · New Hope, US
David Thomas Parker · Cambridge, US
Yunshan Peng · Arlington, US
Stefan Peukert · Frankfurt am Main, DE
Nichola Smith · Horsham, GB
Ken Yamada · Brookline, US
Kayo Yasoshima · Cambridge, US

Key dates

Filing date	Oct 15, 2020
Grant date	Dec 20, 2022
Priority date	—
Expiry date	Oct 15, 2040

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07B2200/13
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention provides a compound of formula (I) or a pharmaceutically acceptable salt thereof; Wherein R1, R3-R6, X2 and X3 are as defined herein, a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.